Lumbal Erector Spinae Plane Block for Pain Management After Total Hip Arthroplasty

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-85
SponsorUniversity Tunis El Manar

About this trial

The Erector Spinae Plane (ESP) block or spinal erector block was first described in September 2016 by a Canadian team. It's a block that was initially used for the treatment of chronic thoracic neuropathic pain. The ESP block is one of the inter-fascicular blocks and it's an easy-to-perform technique.In the literature, it has been reported that Lumbar ESPB provides effective analgesia after a hip surgery.

The purpose of this prospective randomized study was to compare the analgesic effects of the ultrasound-guided lumbar Erector Spinae Plane block on postoperative pain management versus the multimodal analgesia after total hip arthroplasty.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

primary total hip arthroplasty with lateral approach and under general anesthesia .

Disqualifiers

• Contraindication or refusal to regional anesthesia

Contraindication to non-steroidal anti-inflammatory (NSAID's)

Allergy to opioids

Allergy to paracetamol

Trial design

Design model

Sequential

Treatments tested in this trial

  • Lumbal Erector Spinae Plane Block

    Procedure/Surgery

    Lumbar ESP block performed after anesthesia induction. A low-frequency ultrasound probe will be placed longitudinally 2-3 cm lateral to the L4 transverse process. Erector spinae muscle will be visualized on the hyperechoic transverse process. The block needle (100 mm, 22G) will be inserted cranio-caudal direction and following confirmation of the correct position of the needle, between the erectorspinae muscle and the transverse process,30 ml of local anesthetic (0.25% bupivacaine/0.2% ropivacaine) will be administered for the block.

  • intravenous pain killers

    Procedure/Surgery

    intravenous pain killers

Treatment groups

60 Participants
are divided into 2 treatment groups
Group A: hip arthroplasty with nerve blockActive comparator 1 intervention
Group B: hip arthroplasty with intravenous pain killersPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

morphine consumption

total morphine dose

Time frame
Day 1

Secondary outcomes

1

pain scores

numerical pain rating scale \[1 to 10 worse outcome\]

Time frame
Hour 2, Hour 4, Hour 6, Hour 12, Hour 18, Hour 24 and on Day 2 and Day 7.
2

intraoperative opioid consumption

total fentanyl dose

Time frame
end of surgery
3

pain on sitting position

numerical pain rating scale \[1 to 10 worse outcome\]

Time frame
Day 1
4

QR 9 score

quality of recovery score \[0 to 18 best outcome\]

Time frame
Day 2

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.